
ICU Medical ICUI
$ 149.56
-0.31%
Quarterly report 2025-Q3
added 11-06-2025
ICU Medical Interest Expense 2011-2026 | ICUI
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense ICU Medical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107 M | 103 M | 70.8 M | 858 K | 1.75 M | 549 K | 709 K | 2.05 M | 118 K | 39 K | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 107 M | 39 K | 28.6 M |
Quarterly Interest Expense ICU Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.8 M | 20.5 M | 22 M | - | 24.7 M | 23.8 M | 23.8 M | - | 24.2 M | 24.1 M | 22.5 M | - | 17.8 M | 15.4 M | 13.6 M | - | 168 K | 163 K | 161 K | - | 616 K | 771 K | 967 K | - | 139 K | 139 K | 133 K | - | 283 K | 130 K | 135 K | - | 705 K | 525 K | 513 K | - | 58 K | 48 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 24.7 M | 48 K | 8.9 M |
Interest Expense of other stocks in the Medical instruments industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
149 | - | - | $ 810 M | ||
|
Baxter International
BAX
|
408 M | $ 19.92 | 0.94 % | $ 10.2 B | ||
|
Repro Med Systems
KRMD
|
561 K | $ 5.36 | -1.65 % | $ 244 M | ||
|
OraSure Technologies
OSUR
|
-380 K | $ 2.74 | -1.79 % | $ 204 M | ||
|
Ekso Bionics Holdings
EKSO
|
-1 K | $ 8.65 | 3.1 % | $ 174 M | ||
|
Alcon
ALC
|
192 M | $ 80.83 | -0.37 % | $ 40.4 B | ||
|
AtriCure
ATRC
|
-326 K | $ 36.3 | -1.76 % | $ 1.7 B | ||
|
Haemonetics Corporation
HAE
|
-9.75 M | $ 65.68 | -0.42 % | $ 3.31 B | ||
|
electroCore
ECOR
|
6.3 M | $ 6.88 | -3.1 % | $ 37.9 K | ||
|
AngioDynamics
ANGO
|
4.94 M | $ 10.13 | 1.5 % | $ 414 M | ||
|
InfuSystem Holdings
INFU
|
1.4 M | $ 8.1 | 0.56 % | $ 167 M | ||
|
STERIS plc
STE
|
8.4 M | $ 260.7 | -0.36 % | $ 25.7 B | ||
|
The Cooper Companies
COO
|
-16.4 M | $ 80.7 | 0.41 % | $ 16.1 B | ||
|
Masimo Corporation
MASI
|
300 K | $ 134.15 | -1.54 % | $ 7.15 B | ||
|
Harvard Bioscience
HBIO
|
-227 K | $ 0.49 | -8.67 % | $ 20.8 M | ||
|
Glaukos Corporation
GKOS
|
13.6 M | $ 117.26 | -1.52 % | $ 5.68 B | ||
|
Merit Medical Systems
MMSI
|
-711 K | $ 80.09 | -0.19 % | $ 4.66 B | ||
|
Isoray
ISR
|
2 K | - | 0.03 % | $ 108 M | ||
|
iRhythm Technologies
IRTC
|
1.25 M | $ 148.9 | -0.06 % | $ 4.65 B | ||
|
LeMaitre Vascular
LMAT
|
205 K | $ 84.46 | 0.72 % | $ 1.9 B | ||
|
Utah Medical Products
UTMD
|
256 K | $ 60.61 | -1.69 % | $ 220 M | ||
|
Microbot Medical
MBOT
|
2 K | $ 1.82 | -2.15 % | $ 18.6 M | ||
|
Nephros
NEPH
|
2 K | $ 4.4 | 0.23 % | $ 45.7 M | ||
|
Milestone Scientific
MLSS
|
60.3 K | $ 0.3 | -1.38 % | $ 23.9 M | ||
|
Envista Holdings Corporation
NVST
|
-100 K | $ 23.08 | -1.33 % | $ 3.97 B | ||
|
Pro-Dex
PDEX
|
533 K | $ 37.95 | -3.69 % | $ 125 M | ||
|
Predictive Oncology
POAI
|
3 | - | - | $ 31.1 M | ||
|
Pulse Biosciences
PLSE
|
983 K | $ 13.88 | 1.91 % | $ 667 M | ||
|
Becton, Dickinson and Company
BDX
|
613 M | $ 201.3 | 0.11 % | $ 57.9 B | ||
|
Repligen Corporation
RGEN
|
8.12 M | $ 152.02 | -2.78 % | $ 8.47 M | ||
|
ResMed
RMD
|
3.2 M | $ 250.46 | -2.78 % | $ 36.6 B | ||
|
BioLife Solutions
BLFS
|
497 K | $ 21.94 | -2.85 % | $ 1.01 B | ||
|
Stereotaxis
STXS
|
1.1 M | $ 2.24 | -3.86 % | $ 181 M | ||
|
Retractable Technologies
RVP
|
227 K | $ 0.69 | -2.01 % | $ 20.7 M | ||
|
STAAR Surgical Company
STAA
|
815 K | $ 18.74 | -1.06 % | $ 921 M | ||
|
Teleflex Incorporated
TFX
|
57 M | $ 105.09 | -0.37 % | $ 4.92 B | ||
|
West Pharmaceutical Services
WST
|
-1 M | $ 225.53 | -3.06 % | $ 16.5 B | ||
|
DENTSPLY SIRONA
XRAY
|
12 M | $ 12.32 | 0.37 % | $ 2.5 B |